Isolation of a peptide antagonist to the thrombin receptor using phage display.
The thrombin receptor on platelets is an integral membrane protein and is cleaved by thrombin to expose a "tethered ligand" that binds to and triggers the receptor. Here we have explored the power of phage selection technology to make a peptide antagonist of this receptor using platelets directly for the selection. To focus the selection to the thrombin receptor, we eluted the phage with a peptide agonist of the thrombin receptor. A repertoire (1 x 10(7) phage clones) displaying peptide sequences based on the sequence of the tethered ligand, was constructed and selected by binding to the platelets. After several rounds of selection, we identified phage clones that were able to immunoprecipitate the thrombin receptor from platelets and the encoded peptides were sequenced. This revealed some features in common with the tethered ligand, in particular an arginine residue followed by a proline. Several of the peptides were synthesized chemically and one of the peptides was shown to antagonise platelet aggregation triggered by the agonist peptide, and to inhibit serotonin release and tyrosine phosphorylation triggered by either thrombin or the agonist peptide. Anti-aggregatory activity was about ten-fold higher than that of previously reported peptide antagonists of the thrombin receptor.
Doorbar
J
J
MRC Centre for Protein Engineering, Cambridge, U.K.
Winter
G
G
D000595:Amino Acid Sequence; D001435:Bacteriophages; D001483:Base Sequence; D001792:Blood Platelets / Q000737:chemistry; D007118:Immunoassay; D008024:Ligands; D008969:Molecular Sequence Data; D010455:Peptides / Q000494:pharmacology; D010766:Phosphorylation; D010974:Platelet Aggregation; D011233:Precipitin Tests; D018179:Receptors, Thrombin / Q000037:antagonists & inhibitors*; D012701:Serotonin / Q000096:biosynthesis; D014443:Tyrosine / Q000378:metabolism
D008024:Ligands; D010455:Peptides; D018179:Receptors, Thrombin; D012701:Serotonin; D014443:Tyrosine